Hamps Bio appoints Ravi Baheti as Company Secretary and Compliance Officer
Hamps Bio Limited has appointed Mr. Ravi Baheti as Company Secretary and Compliance Officer effective July 6, 2026, following the resignation of Ms. Komal Jain effective June 30, 2026. The Board approved the changes to ensure governance continuity, complying with SEBI regulations.

*this image is generated using AI for illustrative purposes only.
Hamps Bio Limited has appointed Mr. Ravi Baheti as its Company Secretary and Compliance Officer, effective July 6, 2026. This decision follows the resignation of Ms. Komal Jain from the same position, which was effective from the close of business hours on June 30, 2026. The Board approved these changes during its meeting held on July 6, 2026, to ensure continuity in the company's compliance and governance functions.
The resignation of Ms. Jain was attributed to personal reasons, and she confirmed there were no other material factors for her departure. The company disclosed these details in a filing submitted to BSE Limited, complying with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was signed by Managing Director Herrick Mountbaton Shah.
Details of Appointment
Mr. Baheti brings over nine years of experience in secretarial work to the role. He is an Associate Member of the Institute of Company Secretaries of India (ICSI), holding Membership No. A49472, and possesses a Bachelor's degree in Commerce (Hons). His expertise includes corporate governance, drafting, compliance management, and other allied secretarial functions.
| Particulars | Remarks |
|---|---|
| Reason for change | Appointment of Mr. Ravi Baheti as a Company Secretary and Compliance Officer. |
| Date of Appointment | W.e.f 06th July, 2026 |
| Brief Profile | Associate Member of ICSI (Membership No. A49472). Holds B.Com (Hons). Over 9 years of experience in secretarial work, corporate governance, and compliance. |
Details of Cessation
The transition was formalized under the provisions of SEBI circular SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023. The Board also authorized Key Managerial Personnel (KMP) to determine the materiality of events or information for disclosures to the stock exchanges pursuant to Regulation 30(5) of the SEBI Listing Regulations.
| Particulars | Remarks |
|---|---|
| Reason for change | Due to personal reason. |
| Date of Cessation | Closing business hours of 30th June, 2026 |
Historical Stock Returns for Hamps Bio
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | 0.0% | +2.10% | +45.75% | +35.10% | -48.40% |
How will Mr. Baheti's appointment influence Hamps Bio's future compliance and governance strategies?
What impact might this leadership change have on the company's relationship with SEBI and BSE?
Could the transition in the compliance officer role lead to any shifts in Hamps Bio's disclosure practices?































